{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:57:14Z","timestamp":1792065434355,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010544","name":"Exelixis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.adro.2026.102075","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:30:04Z","timestamp":1778891404000},"page":"102075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8617-966X","authenticated-orcid":false,"given":"Rafael Lara","family":"Nohmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricia Cardoso","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa Carneiro","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana de Moura","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel V.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102075_bib0001","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102075_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa2401726","article-title":"Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma","volume":"392","author":"Apolo","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102075_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.24.00340","article-title":"Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: Expanded efficacy from CheckMate 274","volume":"43","author":"Galsky","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0004","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.adro.2026.102075_bib0005","doi-asserted-by":"crossref","first-page":"S1648","DOI":"10.1016\/j.annonc.2025.09.124","article-title":"Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study","volume":"36","author":"Vulsteke","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0006","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(03)13580-5","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102075_bib0007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant chemotherapy for invasive bladder cancer: A 2013 updated systematic review and meta-analysis of randomized trials","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102075_bib0008","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0022-5347(01)66693-X","article-title":"The relationship of local control to distant metastasis in muscle invasive bladder cancer","volume":"154","author":"Pollack","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2026.102075_bib0009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijrobp.2012.03.061","article-title":"Bladder cancer patterns of pelvic failure: Implications for adjuvant radiation therapy","volume":"85","author":"Baumann","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102075_bib0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.28544","article-title":"Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710","volume":"120","author":"Christodouleas","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2026.102075_bib0011","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0360-3016(92)90005-3","article-title":"Postoperative radiotherapy of carcinoma in bilharzial bladder: Improved disease free survival through improving local control","volume":"23","author":"Zaghloul","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102075_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: A randomized phase 2 trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.adro.2026.102075_bib0013","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ijrobp.2024.05.012","article-title":"The value and safety of adjuvant radiation therapy after radical cystectomy in locally advanced urothelial bladder cancer: A controlled randomized study","volume":"120","author":"Zaghloul","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102075_bib0014","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.adro.2026.102075_bib0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijrobp.2024.09.040","article-title":"Bladder adjuvant radiation therapy (BART): Acute and late toxicity from a phase III multicenter randomized controlled trial","volume":"121","author":"Murthy","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl","key":"10.1016\/j.adro.2026.102075_bib0016","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ijrobp.2025.06.1007","article-title":"Bladder adjuvant radiotherapy (BART): Clinical outcomes from a phase III multicenter randomized controlled trial","volume":"123","author":"Murthy","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102075_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: Reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.adro.2026.102075_bib0018","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available at: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf. Accessed April 15, 2025"},{"key":"10.1016\/j.adro.2026.102075_bib0019","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.adro.2026.102075_bib0020","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.adro.2026.102075_bib0021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.adro.2026.102075_bib0022","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14640","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"123","author":"Assel","year":"2019","journal-title":"BJU Int."},{"key":"10.1016\/j.adro.2026.102075_bib0023","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/BLC-220031","article-title":"Adjuvant chemotherapy plus radiotherapy versus chemotherapy alone for locally advanced bladder cancer after radical cystectomy","volume":"8","author":"Ernandez","year":"2022","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.adro.2026.102075_bib0024","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1002\/cam4.2102","article-title":"Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer","volume":"8","author":"Fischer-Valuck","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.adro.2026.102075_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.euo.2018.11.010","article-title":"National practice patterns and overall survival after adjuvant radiotherapy following radical cystectomy for urothelial bladder cancer in the USA, 2004-2013","volume":"3","author":"Bateni","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/BLC-180163","article-title":"The role of adjuvant radiation therapy in locally advanced bladder cancer","volume":"4","author":"Lewis","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.adro.2026.102075_bib0027","doi-asserted-by":"crossref","unstructured":"Verlage K, Isharwal S. Utilization and outcomes of adjuvant radiation therapy after cystectomy for urothelial carcinoma. J Clin Oncol. 37(suppl):487.","DOI":"10.1200\/JCO.2019.37.7_suppl.487"},{"key":"10.1016\/j.adro.2026.102075_bib0028","first-page":"47","article-title":"Prognostic index for primary adenocarcinoma of the urinary bladder","author":"Zaghloul","year":"2007","journal-title":"Gulf J Oncolog"},{"key":"10.1016\/j.adro.2026.102075_bib0029","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2006.06.025","article-title":"Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder","volume":"176","author":"Karakiewicz","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2026.102075_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-11-16","article-title":"Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study","volume":"11","author":"Abdel Raheem","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2026.102075_bib0031","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2147\/CMAR.S69055","article-title":"Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients","volume":"6","author":"Bayoumi","year":"2014","journal-title":"Cancer Manag Res"},{"issue":"2 suppl","key":"10.1016\/j.adro.2026.102075_bib0032","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.1016\/j.ijrobp.2016.06.1329","article-title":"The outcomes of adjuvant radiation therapy in postcystectomy muscle-invasive bladder cancer","volume":"96","author":"Tuanquin","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102075_bib0033","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clgc.2016.07.012","article-title":"Adjuvant chemotherapy after radical cystectomy for urothelial bladder cancer: outcome and prognostic factors for survival in a French multicenter, contemporary cohort","volume":"15","author":"Pouessel","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.adro.2026.102075_bib0034","volume":"49","author":"Marcq","year":"2025","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"10.1016\/j.adro.2026.102075_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.urolonc.2011.01.008","article-title":"A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer","volume":"31","author":"El-Monim","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0036","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.euf.2021.11.004","article-title":"Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer: results of a multicentric phase II trial","volume":"8","author":"Fonteyne","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.adro.2026.102075_bib0037","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clon.2021.03.020","article-title":"Adjuvant and neoadjuvant radiation therapy for locally advanced bladder cancer","volume":"33","author":"Baumann","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2026.102075_bib0038","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrclinonc.2016.188","article-title":"Systemic, perioperative management of muscle-invasive bladder cancer and future horizons","volume":"14","author":"Funt","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.18632\/oncotarget.28723","article-title":"Advancements in bladder cancer treatment: the synergy of radiation and immunotherapy","volume":"16","author":"Hasan","year":"2025","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2026.102075_bib0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CCO.0000000000000471","article-title":"The management of locally advanced cervical cancer","volume":"30","author":"Naga","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0041","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.20.00275","article-title":"Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO guideline","volume":"38","author":"Maghami","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102075_bib0042","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.3390\/cancers14102545","article-title":"Immune checkpoint inhibitors as a neoadjuvant\/adjuvant treatment of muscle-invasive bladder cancer: A systematic review","volume":"14","author":"Barone","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:36:27Z","timestamp":1792064187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2452109426000825"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102075","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102075"}}